The Swedish innovation model: “There is a paradox”

It is often said that Sweden is strong when it comes to innovation, but how well are we turning that innovation into actual medicines?

Automated nitrogen analysis reduces costs per sample

N-Realizer analytical system from C. Gerhardt increases productivity with valve block from Festo

No longer afraid of the dentist.

Teaching robot with piezo technology

Neogap får Kinapatent för metod inom MS-behandling

Neogap Therapeutics har beviljats ett patent i Kina för en metod som kan leda till nya metoder för behandling och diagnos inom multipel skleros, MS.

Her company is developing a new tablet form obesity drug

Obesity and diabetes are the primary targets of a new tablet treatment under development by Malmö-based Pila Pharma. The company’s ambition is to take on the bi...

Han tar över som ordförande i CTR

Bengt Dahlström, grundare av Center for Translational Research, har efter sju år som styrelseordförande i koncernen lämnat över ordförandeklubban till Hans Andreasson.

Förlikning i babypuderskandal stoppas av domstol

Det amerikanska läkemedelsbolaget Johnson & Johnson har för en andra gång fått avslag av en domare om en konkursansökan för dotterbolaget LTL Management, mest k...

The Swedish government is to increase its investment in cancer care

The Swedish government wants to invest more in cancer and paediatric cancer care and proposes to allocate SEK 500 million per year for this purpose in the coming years.

Larm om vaccinbrist efter utbrott av difteri i Västafrika

Ett allvarligt utbrott av difteri har drabbat Västafrika. Nu varnar Läkare utan gränser för brist på läkemedel och vaccin mot sjukdomen.

The art of building a biologic drug

The first biosimilar from Xbrane Biopharma was launched earlier this year, and several more are under development at the company’s facility in Solna, Sweden. “W...

Life science trends 2025 – The economy

Upcoming patent expirations are driving pharmaceutical companies to acquire in 2025. In Sweden, we may be on our way to brighter times and fewer bankruptcies. T...

Marie Gårdmark: New incentives for orphan products on its way

"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave fo...

Anna Törner: The minute between life and death

“I have never told anyone about this day that happened more than 20 years ago. But I sometimes reflect on what happened, on what might have happened. When I try...

Nanoparticles to help detect pulmonary disease

Nanoparticles behave in a certain way in the air. Using this knowledge, researchers at Lund University have developed a new measurement method for lung examinations based on the phenomenon....

Accurate removal of prostate tissue

Medical robots play an important role in diagnostics

To build trust, one must be able to say “I don’t know” – whether human or AI

Will AI strengthen or break down trust? It depends on whether we can understand and accept its limitations, and our own, writes Sarah Lidé in a column.

It couldn’t be simpler

AI-assisted ZEISS Solution inspects implant coatings automatically.

Drug development creates new challenges for regulators

”Newsify your equity story!”

En uppmaning till noterade life science-bolag att uppgradera sin kommunikation från ”plikt” till värdebyggare

Precision and accuracy in liquid handling

How to evaluate and optimize liquid handling performance

AstraZeneca moves to brewery quarters in central Copenhagen

AstraZeneca in Denmark is moving its business into central Copenhagen and the old brewery quarters in Carlsberg Byen.

Webinar: What is Regulatory Affairs?

This webinar is intended for those who work within the life science sector and would like to gain a general understanding of regulatory affairs for human medicinal products.

A green nursery for biotech rooted in the Scanian soil

Red Glead has established itself as one of Lund’s largest companies in pharmaceutical development. Life Science Sweden went to Skåne and met two of the founders...

Business Sweden: “Companies have a lot to offer in data-driven precision medicine”

Data-driven precision medicine can potentially solve major healthcare problems, states Business Sweden in a new report on the subject.